Byrna Technologies Announces Preliminary Fiscal Second Quarter Record Revenues of $28.5 Million
Company Achieves 41% Year-Over-Year Growth Driven by Compact Launcher Rollout and Retail…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…